Disc Medicine, Inc. Common Stock
$69.53
Market Cap
$2.67B
Shares Outstanding
38.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 8, 2021
Round Lot
100
Locale
US
Day Open
$69.13
Day High
$69.60
Day Low
$67.70
Volume
1.08M
VWAP
$69.14
Prev Close
$69.18
Transactions
--
Acc. Volume
--
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Disc Medicine, Inc. Common Stock (IRON) closed the 2026-09-18 session at $69.53, up 0.51% versus the previous close (+0.35). The stock opened at $69.13 and traded between $67.70 and $69.60 during that session. Session trading volume was 1.1M shares. The volume-weighted average price (VWAP) is $69.14.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Disc Medicine, Inc. Common Stock has a market capitalization of $2.67 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. IRON is listed on the XNAS exchange. The company employs approximately 165 people. Disc Medicine, Inc. Common Stock is headquartered in WATERTOWN, MA. The recorded listing date is 2021-02-08.
On this page you can find market IRON stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.